Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42556144)
Watch
English
Metrics for antibody therapeutics development
scientific article published on November 2010
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
editorial
0 references
title
Metrics for antibody therapeutics development
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
main subject
antibody
1 reference
based on heuristic
inferred from title
author
Janice M. Reichert
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
publication date
1 November 2010
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
published in
Monoclonal Antibodies
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
volume
2
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
issue
6
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
page(s)
695-700
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
cites work
Development trends for human monoclonal antibody therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
The future of monoclonal antibody technology
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
New challenges to medicare beneficiary access to mAbs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
Monoclonal antibodies as innovative therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
The impact of PEGylation on biological therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
Single-domain antibodies as building blocks for novel therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
Properties, production, and applications of camelid single-domain antibody fragments
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
Antibody engineering: facing new challenges in cancer therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
Can the pharmaceutical industry reduce attrition rates?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
Engineered antibodies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
Monoclonal antibodies in the clinic.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
28 May 2018
Development trends for therapeutic antibody fragments.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3011223
retrieved
16 August 2018
Improved tumor targeting with chemically cross-linked recombinant antibody fragments
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20930555
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Monoclonal antibody successes in the clinic
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20930555
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.4161/MABS.2.6.13603
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
PMCID
3011223
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
PubMed ID
20930555
1 reference
stated in
Europe PubMed Central
PMCID
3011223
retrieved
2 November 2017
ResearchGate publication ID
47370641
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
